Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed

This funding opportunity provides support for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. The main objective is to support platform-oriented technology development associated with the production, manufacturing, and use of extracellular vesicles as therapeutics in regenerative medicine. • The opportunity is open to small businesses. • The award ceiling is $295,924. • The opportunity is for the development of novel extracellular vesicle-based therapeutic platforms. • The main objective is to support platform-oriented technology development associated with the production, manufacturing, and use of extracellular vesicles as therapeutics in regenerative medicine.